GSTP1 and prostate carcinoma: In this study, we demonstrate that 5-aza-CdR, at a dose of 0.5 μM given daily, completely inhibited cell proliferation and induced cell death in prostate cancer cells, and was associated with demethylation of the GSTP1 promoter and re-expression of GSTP1 protein.